Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia.

Aksari Dewi Elizabeth PisaniBachtiar Rifai Pratita IhsanAyuk Lawuningtyas Hariadini Anushka Patel Anna Palagyi Devarsetty Praveen Sujarwoto SujarwotoDiana Lyrawati

Published in: Journal of pharmaceutical policy and practice (2023)

Fears that COVID-19 would interrupt medicine availability were unfounded in East Java. Public sector patients may have compensated for reduced service access by switching to private pharmacies. Mitigation policies that ignored administrative procedures were not effective.

Keyphrases

healthcare
end stage renal disease
mental health
newly diagnosed
coronavirus disease
ejection fraction
sars cov
public health
chronic kidney disease
prognostic factors
climate change
emergency department
patient reported outcomes
combination therapy
smoking cessation
replacement therapy